BOSTON—AdvaMed, the Medtech Association, concluded The MedTech Conference 2026, convening more than 4,470 attendees from 2,050 companies from 40 countries for the global medtech industry’s premier annual gathering.
Held October 18-21 at the Thomas M. Menino Convention and Exhibition Center in Boston, the conference drew medtech CEOs, innovators, investors, policymakers, regulators, health care leaders, patient advocates, and emerging companies for four days of programming, business development, company presentations, and technology demonstrations.
Partnering activity increased 25 percent over 2025, with 3,880 scheduled meetings, underscoring the conference’s growing role in connecting industry leaders, accelerating business development opportunities, and advancing medtech innovation.
“The MedTech Conference 2026 once again showed why this is the premier gathering in medtech,” said Scott Whitaker, president and CEO of AdvaMed. “Across the Medtech Campus, the keynote stage, company presentations, and one-on-one conversations throughout the week, the energy in Boston reflected the strength of this community and the purpose that brings us together: helping more patients live healthier, longer, fuller lives.
“I’m especially grateful to our conference steering co-chairs, Mike Mahoney of Boston Scientific, Ashley McEvoy of Insulet, and Jonathan Rennert of ZOLL; program committee chair Sonal Matai of KARL STORZ; host chair Brian Johnson of MassMEDIC; and Mick Farrell of Resmed for their leadership and partnership. I also want to thank our sponsors, exhibitors, speakers, attendees, member companies, Board members, committee leaders, and the AdvaMed team that made this conference possible. The MedTech Conference stands apart because we come together with purpose, collaboration, and an unwavering commitment to patients.”
The 2026 conference reflected strong momentum across the medtech ecosystem, including record AdvaMed member company participation, expanded international engagement, and AdvaMed’s largest Medtech Campus to date. Programming featured more than 600 speakers and more than 185 company presentations, with sessions on major industry priorities including artificial intelligence and digital health, business development and investment, diagnostics, imaging, regulatory policy, Medicare coverage and payment, global market access, supply chain resilience, compliance, and patient access.
The Medtech Campus featured the Patient Pavilion, elevating patient perspectives alongside hands-on demonstrations, emerging technologies, company presentations, investor and partnering opportunities, and live programming connecting innovators with potential partners, investors, customers, policymakers, and industry leaders. The Campus also included the Tech in Motion Hub, where AdvaMed opened the conference with a ribbon-cutting featuring Scott Whitaker, Mick Farrell, Ashley McEvoy, Jonathan Rennert, Sonal Matai, and Brian Johnson.
Keynote programming underscored the conference’s role as a forum for conversations shaping the future of health care. Scott Whitaker opened the conference with remarks on the value of medical technology to patients, families, the health care system, and the economy. Massachusetts Gov. Maura Healey welcomed attendees to Boston and highlighted the region’s life sciences and innovation leadership. Gov. Tim Walz of Minnesota provided special remarks and toured the conference.
The Monday keynote program also featured a Johnson & Johnson MedTech-supported Operation Smile segment with Dr. William Magee III, DDS, MD, chief medical officer of Operation Smile, bringing a patient-centered global health perspective and emphasizing the important role that partnerships bring to patient care.
Monday’s keynote session “Pulse on Medtech: The Best Opportunities in Medtech for 2026-2027” featured Mick Farrell, chairman and CEO of Resmed and chair of the AdvaMed Board of Directors; Mike Mahoney, chairman and CEO of Boston Scientific; Ashley McEvoy, director, president and CEO of Insulet; and Robbie Marcus, medtech senior analyst at J.P. Morgan, in a conversation moderated by John Babitt, EY partner and global medtech leader.
Tuesday’s keynote program featured remarks from Mick Farrell and Mike Minogue, a pioneering former medtech CEO who previously chaired the AdvaMed Board, and the presentation of AdvaMed’s 2026 Lifetime Achievement Award to Vince Forlenza, chairman of the board of Moody’s Corporation and former chairman and CEO of BD. The conference also recognized John Jaeckle, chief regulatory affairs strategist at GE HealthCare, with the 2026 AdvaMed Imaging Röntgen Award, and Scott Garrett with the 2026 AdvaMedDx Lifetime of Leadership & Service Award.
Brian Moynihan, chair of the board and CEO of Bank of America, joined Geoff Martha, chairman and CEO of Medtronic, for a fireside chat on the economy, investment, and medtech’s opportunities ahead. The program also highlighted Bank of America’s expanded investor and dealmaking programming at The MedTech Conference.
The conference concluded Wednesday with the annual FDA Center for Devices and Radiological Health Town Hall, featuring CDRH Director Dr. Michelle Tarver and senior CDRH leaders Rick Abramson, Owen Faris, Angela Krueger, and Edward Margerrison. The session gave attendees direct access to FDA leadership discussing regulatory priorities, review practices, and the future of medical device innovation.
Additional 2026 highlights included expanded investor programming and business development opportunities; 24 corporate reverse pitches showcasing partnership and investment priorities; the military health-focused Pitch & Pour Start-up Pitch Competition featuring 12 early-stage companies; dedicated programming for students, veterans, and early-career professionals; MedTech Color’s 9th Annual Networking Breakfast, centered on the theme “Where Inclusive Collaboration Meets Health Impact”; and international engagement from Europe, the United Kingdom, Central America, and a new Nordic-Baltic delegation.
The conference also featured CEOs Unplugged, the MedTech Innovator Showcase and Finals, AdvaMed Accel programming, panel discussions, networking receptions, and 3,880 scheduled partnering meetings. Together, the programming reflected the breadth of today’s medtech ecosystem, from medical devices, diagnostics, digital health, and medical imaging to artificial intelligence and emerging growth companies. Please see news releases on small company innovation award winners and the 13th Annual Pediatric Device Symposium, including innovation awards, here and here.
AdvaMed thanked its 2026 sponsors, including Bank of America, Abbott, BD, Dexcom, EY, Johnson & Johnson MedTech, Medtronic, PwC, Philips, Solventum, Boston Scientific, IQVIA, Google, Medmarc, McKinsey, Microsoft, Resmed, Smith + Nephew, Steris, Stryker, and Olympus, for their support of this year’s conference.
The next MedTech Conference will be held in San Francisco, October 3-6, 2027.
###
Call to Action Heading…
Call to Action Description…